Cyclophilin and Gag in HIV-1 Replication and Pathogenesis

  • Ettaly Kara Franke
  • Jeremy Luban

Abstract

The gag gene products perform many functions in the retroviral life cycle. Recent work suggests that specific binding of HIV-1 Gag to the cellular proteins known as the cyclophilins is necessary for viral infectivity and perhaps of importance to the immunopathology associated with HIV infection. Cyclophilins are ubiquitous prolyl isomerases thought to function as chaperones. Members of this family of proteins are required for the immunosuppression induced by cyclosporin A and are suspected regulators of cellular activation pathways. Here we review the functions of the gag proteins, what is known about the Gag-cyclophilin interaction, and the possible relevence of this interaction for HIV-1 replication and pathogenesis.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aldrovandi, G. M., G. Feuer, L. Gao, B. Jamieson, M. Kristeva, I. S. Y. Chen and J. A. Zack. 1993. The SCID-hu mouse as a model for HIV-1 infection. Nature. 363:732–736.PubMedCrossRefGoogle Scholar
  2. 2.
    Allan, J. S. 1992. Viral evolution and AIDS. J. NIH Res. 4:51–54.Google Scholar
  3. 3.
    Ameisen, J. C. and A. Capron. 1991. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today. 12:102–105.Google Scholar
  4. 4.
    Anderson, S. K., S. Gallinger, J. Roder, J. Frey, H. A. Young and J. R. Ortaldo. 1993. A cyclophilin-related protein involved in the function of natural killer cells. Proc. Natl. Acad. Sci. USA. 90:542–546.PubMedCrossRefGoogle Scholar
  5. 5.
    Andrieu, J.-M., P. Even, A. Venet, J.-M. Tourani, M. Stern, W. Lowenstein, C. Audroin, D. Eme, D. Masson, H. Sors, D. Israel-Biet and K. Beldjord. 1988. Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease. Clin. Immunol. Immunopathol. 46:181–198.CrossRefGoogle Scholar
  6. 6.
    Arthur, L. O., J. W. Bess, R. C. Sowder, R. E. Benveniste, D. L. Mann, J.-C. Chermann and L. E. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science. 258:1935–1938.PubMedCrossRefGoogle Scholar
  7. 7.
    Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R.-P. Sekaly and T. H. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176:1099–1106.PubMedCrossRefGoogle Scholar
  8. 8.
    Bell, K. D., O. Ramilo and E. S. Vitetta. 1993. Combined use of an immunotoxin and cyclosporine to prevent both actvated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 90:1411–1415.PubMedCrossRefGoogle Scholar
  9. 9.
    Bergsma, D. J., C. Eder, M. Gross, H. Kersten, D. Sylvester, E. Appelbaum, D. Cusimano, G. P. Livi, M. M. McLaughlin, K. Kasyan, W. P. Prichett, M. J. Bossard, M. Brandt and M. A. Levy. 1991. The cyclophilin multigene family of peptidyl-prolyl isomerases. J. Biol. Chem. 266:23204–23214.PubMedGoogle Scholar
  10. 10.
    Bierer, B. E., G. Hollander, D. A. Fruman and S. J. Burakoff. 1993. Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Curr. Opin. Immunol. 5:763–773.PubMedCrossRefGoogle Scholar
  11. 11.
    Bonyhadi, M. L., L. Rabin, S. Salimi, D. A. Brown, J. Kosek, J. M. McCune and H. Kaneshima. 1993. HIV induces thymus depletion in vivo. Nature. 363:728–732.PubMedCrossRefGoogle Scholar
  12. 12.
    Bowerman, B., P. O. Brown, J. M. Bishop and H. E. Varmus. 1989. A nucleoprotein complex mediates the integration of retroviral DNA. Gene Dev. 3:469–478.PubMedCrossRefGoogle Scholar
  13. 13.
    Bram, R. J., D. T. Hung, P. K. Martin, S. L. Schreiber and G. Crabtree. 1993. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: Role of calcineurin-binding and cellular location. Mol. Cell. Biol. 13:4760–4769.Google Scholar
  14. 14.
    Bryant, M. and L. Ratner. 1990. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA. 87:523–527.PubMedCrossRefGoogle Scholar
  15. 15.
    Bukrinsky, M. I., S. Haggerty, M. P. Dempsey, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature. 365:666–669.PubMedCrossRefGoogle Scholar
  16. 16.
    Cacalano, N. A., B.-X. Chen, W. L. Cleveland and B. F. Erlanger. 1992. Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes. Proc. Natl. Acad. Sci. USA. 89:4353–4357.PubMedCrossRefGoogle Scholar
  17. 17.
    Cameron, P. U., M. Pope, S. Gezelter and R. M. Steinman 1994. Infection and apoptotic cell death of CD4+ T cells during an immune response to HIV-1-pulsed dendritic cells. Aids Res. Hum. Retro. 10:61–71.CrossRefGoogle Scholar
  18. 18.
    Clipstone, N. A. and G. R. Crabtree. 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature. 357:695–697.PubMedCrossRefGoogle Scholar
  19. 19.
    Colley, N., E. Baker, M. Stamnes and C. Zuker. 1991. The cyclophilin homolog ninaA is required in the secretory pathway. Cell. 67:255–263.PubMedCrossRefGoogle Scholar
  20. 20.
    Delchambre, M., D. Gheysen, D. Thines, C. Thiriart, E. Jacobs, E. Verdin, M. Horth, A. Burny and F. Bex. 1989. The Gag precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J. 8:2653–2660.PubMedGoogle Scholar
  21. 21.
    DesGroseillers, L. and P. Jolicoeur. 1983. Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses. J.Virol. 48:685–696.PubMedGoogle Scholar
  22. 22.
    Durfee, T., K. Becherer, P.-L. Chen, S.-H. Yeh, Y. Yang, A. E. Kilburn, W.-H. Lee and S. J. Elledge. 1993. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7:555–569.PubMedCrossRefGoogle Scholar
  23. 23.
    Dutz, J. P., D. A. Fruman, S. J. Burakoff and B. E. Bierer. 1993. A role for calcineurin in degranulation of murine cytotoxic lymphocytes. J. Immunol. 150:2591–2598.PubMedGoogle Scholar
  24. 24.
    Famet, C. M. and W. A. Haseltine. 1991. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 65:1910–1915.Google Scholar
  25. 25.
    Fields, S. and O. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature. 340:245–246.PubMedCrossRefGoogle Scholar
  26. 26.
    Fischer, G. and F. X. Schmid. 1990. The mechanism of protein folding. Implications of in vitro refolding models for de novo protein folding and translocation in the cell. Biochemistry. 29:2205–2212.PubMedCrossRefGoogle Scholar
  27. 27.
    Fischer, G., B. Wittmann-Liebold, K. Lang, T. Kiefhaber and F. X. Schmid 1989. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature. 337:476–478.PubMedCrossRefGoogle Scholar
  28. 28.
    Franke, E. K., H. E.-H. Yuan, K. L. Bossolt, S. P. Goff and J. Luban. 1994. Specificity and sequence requirements for interactions between various retroviral Gag proteins. J. Virol. 68:5300–5305.PubMedGoogle Scholar
  29. 29.
    Franke, E. K., H. E.-H. Yuan and J. Luban. 1994. Specific incorporation of Cyclophilin A into HIV-1 virions. Submitted.Google Scholar
  30. 30.
    Friedman, J. and I. Weissman. 1991. Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA. Cell. 66:799–806.PubMedCrossRefGoogle Scholar
  31. 31.
    Fruman, D A, S J Burakoff and B. E. Bierer. 1994. Immunophilins in protein folding and inununosuppression. FASEB J. 8:391–400.PubMedGoogle Scholar
  32. 32.
    Fruman, D. A., P. E. Mather, S. J. Burakoff and B. E. Bierer. 1992. Correlation of calcineurin phosphatase activity and programmed cell death in murine T cell hybridomas. Fur. J. Immunol. 22:2513–2517.Google Scholar
  33. 33.
    Garcia, V. and A. D. Miller. 1991. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature. 350:508–511.PubMedCrossRefGoogle Scholar
  34. 34.
    Gaynor, R. B., M. D. Kuwabara, F. K. Wu, J. A. Garcia, D. Harrich, M. Briskin, R. Wall and D. S. Sigman. 1988. Proc. Natl. Acad. Sci. USA. 85:9406–9410.CrossRefGoogle Scholar
  35. 35.
    Gething, M.-J. and J. Sambrook. 1992. Protein folding in the cell. Nature. 355:33–45.PubMedCrossRefGoogle Scholar
  36. 36.
    Gheysen, D., E. Jacobs, F. de Foresta, C. Thiriart, M. Francotte, D. Thines and M. DeWilde. 1989. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell. 59:103–112.PubMedCrossRefGoogle Scholar
  37. 37.
    Gottlinger, H. G., T. Dorfman, E. A. Cohen and W. A. Haseltine. 1993. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. USA. 90:7381–7385.PubMedCrossRefGoogle Scholar
  38. 38.
    Gottlinger, H. G., J. G. Sodroski and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci., USA. 86:5781–5785.PubMedCrossRefGoogle Scholar
  39. 39.
    Groux, H., G. Torpier, D. Monte, Y. Mouton, A. Capron and J. Ameisen. 1992. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331–340.PubMedCrossRefGoogle Scholar
  40. 40.
    Haendler, B., R. Hofer-Warbinek and E. Hofer. 1987. Complementary DNA for human T-cell cyclophilin. EMBO J. 6:947–950.PubMedGoogle Scholar
  41. 41.
    Hahn, B. H. 1994. Viral genes and their products. 21–43. In Textbook of AIDS Medicine, ed. Broder, M. and Bolognesi. Williams and Wilkins., Baltimore.Google Scholar
  42. 42.
    Handschumacher, R., M. Harding, J. Rice and R. Drugge. 1984. Cyclophilin: A specific cytosolic binding protein for cyclosporin A. Science. 226:544–547.PubMedCrossRefGoogle Scholar
  43. 43.
    Harding, M. W., R. E. Handschumacher and D. W. Speicher. 1986. Isolation and amino acid sequence of cyclophilin J Biol. Chem. 261:8547–8555.PubMedGoogle Scholar
  44. 44.
    Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cipl is a potent inhibitor of Gl cyclin-dependent kinases. Cell. 75:805–816.PubMedCrossRefGoogle Scholar
  45. 45.
    Hasel, K. W., J. R. Glass, M. Godbout and J. G. Sutcliffe. 1991. An endoplasmic reticulum-specific cyclophilin. Mol. Cell. Biol. 11:3484–3491.PubMedGoogle Scholar
  46. 46.
    Hopkins, N., J. Schindler and R. Hynes. 1977. Six NB-tropic murine leukemia viruses derived from a B-tropic virus of BALB/c have altered P30. J Virol. 21:309–318.PubMedGoogle Scholar
  47. 47.
    Hsu, H. W., P. Schwartberg and S. P. Goff. 1985. Point mutations in the p30 domain of the gag gene of Moloney leukemia virus. Virology. 142:211–214.PubMedCrossRefGoogle Scholar
  48. 48.
    Imberti, L., A. Sottini, A. Bettinardi, M. Puoti and D. Primi. 1991. Selective depletion in HIV infection of T cells that bear specific T cell receptor VB sequences. Science. 254:860–862.PubMedCrossRefGoogle Scholar
  49. 49.
    Iwabuchi, K., B. Li, P. Bartel and S. Fields. 1993. Use of the two-hybrid system to identify the domain of p53 involved in oligomerization. Oncogene. 8:1693–1696.PubMedGoogle Scholar
  50. 50.
    Jain, J., P. G. McCaffrey, Z. Miner, T. K. Kerppola, J. N. Lamert, G. L. Verdine, T. Curran and A. Rao. 1993. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature. 365:352–355.PubMedCrossRefGoogle Scholar
  51. 51.
    Kaelin, W., D. Pallas, J. De Caprio, F. Kaye and D. Livingston. 1991. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell. 64:521–532.PubMedCrossRefGoogle Scholar
  52. 52.
    Kappes, J. C., J. S. Parkin, J. A. Conway, J. Kim, C. G. Brouillette, G. M. Shaw and B. H. Hahn. 1993. Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. Virology. 193:222–233.PubMedCrossRefGoogle Scholar
  53. 53.
    Karpas, A., M. Lowdell, S. Jacobson and F. Hill. 1992. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK506. Proc. Natl. Acad. Sci. USA. 89:8351–8355.PubMedCrossRefGoogle Scholar
  54. 54.
    Kestler, J. W., D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 65:651–663.PubMedCrossRefGoogle Scholar
  55. 55.
    Kieffer, L. J., T. W. Seng, W. Li, D. G. Osterman, R. E. Handschumacher and R. M. Bayney. 1993. Cyclophilin-40, a protein with homology to the P59 component of the steroid receptor complex. J. Biol. Chem. 268:12303–12310.PubMedGoogle Scholar
  56. 56.
    Klimkait, T., K. Strebel, M. D. Hoggan, M. A. Martin and J. M. Orenstein. 1990. The human immunodeficiency virus type -specific protein Vpu is required for efficient virus maturation and release. J. Virol. 64:621–629.PubMedGoogle Scholar
  57. 57.
    Kofron, J. L., P. Kuzmic, V. Kishore, E. Colon-Bonilla and D. H. Rich. 1991. Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotmetric assay. Biochemistry. 30:6127–6134.PubMedCrossRefGoogle Scholar
  58. 58.
    Koga, Y., M. Sasaki, H. Yoshida, H. Wigzell, G. Kimura and K. Nomoto. 1990. Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV. J. Immunol 144:94–102.PubMedGoogle Scholar
  59. 59.
    Kohl, N. E., E. A. Emini, W. A. Schleif, L. J. Davis, J. C. Heimbach, R. A. Dixon, E. M. Scolnick and I. S. Sigal. 1988. Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. USA. 85:4686–4690.PubMedCrossRefGoogle Scholar
  60. 60.
    Koletsky, A. J., M. W. Harding and R. E. Handschumacher. 1986. Cyclophilin: distribution and variant properties in normal and neoplastic tissues. J. Immunol 137:1054–1059.PubMedGoogle Scholar
  61. 61.
    Lane, H., J. Depper, W. Greene, G. Whalen, T. Waldmann and A. Fauci. 1985. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. N Eng J Med. 313:79–84.CrossRefGoogle Scholar
  62. 62.
    Laurent-Crawford, A., B. Krust, S. Muller, Y. Riviere, M.-A. Rey-Cuille, J.-M. Bechet, L. Montagnier and A. Hovanessian. 1991. The cytopathic effect of HIV is associated with apoptosis. Virology. 185:829–839.PubMedCrossRefGoogle Scholar
  63. 63.
    La allee, C., X. J. Yao, A. Ladha, H. Gottlinger, W. A. Haseltine and E. A. Cohen. 1994. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. J. Virol. 68:1926–1934.Google Scholar
  64. 64.
    Lilly, F. and T. Pincus. 1973. Genetic control of murine viral leukemogenesis. Adv. Cancer Res. 17:231–277.CrossRefGoogle Scholar
  65. 65.
    Linial, M. L. and A. D. Miller. 1990. Retroviral RNA packaging: sequence requirements and implications. Curr. Top. Microbiol. Immunol. 157:125–152.PubMedCrossRefGoogle Scholar
  66. 66.
    Liu, J., M. Alber, T. Wandless, S. Luan, D. Alberg, P. Belshaw, P. Cohen, C. MacKintosh, C. Klee and S. Schreiber. 1992. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochem. 31:3896–3901.CrossRefGoogle Scholar
  67. 67.
    Lodish, H. and N. Kong. 1991. Cyclosporin A inhibits an initial step in folding of transferrin within the endoplasmic reticulum. J. Biol. Chem. 266:14835–14838.PubMedGoogle Scholar
  68. 68.
    Lu, Y.-L., P. Spearman and L. Ratner. 1993. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67:6542–6550.PubMedGoogle Scholar
  69. 69.
    Luban, J., K. B. Alin, K. L. Bossolt, T. Humaran and S. P. Goff. 1992. Genetic assay for multimerization of retroviral gag polyproteins. J. Virol. 66:5157–5160.PubMedGoogle Scholar
  70. 70.
    Luban, J., K. A. Bossolt, E. K. Franke, G. V. Kalpana and S. P. Goff. 1993. Human immunodeficiency virus type 1 gag protein binds to cyclophilins A and B. Cell. 73:1067–1078.PubMedCrossRefGoogle Scholar
  71. 71.
    Luban, J. and S. Goff. 1991. Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein. J. Virol. 65:3203–3212.PubMedGoogle Scholar
  72. 72.
    Luban, J., C. Lee and S. P. Goff. 1993. Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria. J. Virol. 67:3630–3634.PubMedGoogle Scholar
  73. 73.
    Luria, S., I. Chambers and P. Berg. 1991. Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA. 88:5326–5330.PubMedCrossRefGoogle Scholar
  74. 74.
    Mammano, E, A. Ohagen, S. Hoglund and H. G. Gottlinger. 1994. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. In press.Google Scholar
  75. 75.
    McCaffrey, P. G., C. Luo, T. K. Kerppola, J. Jain, T. M. Badalian, A. M. Ho, E. Burgeon, W. S. Lane, J. N. Lambert, T. Curran, G. L. Verdine, A. Rao and P. G. Hogan. 1993. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science. 262:750–754.PubMedCrossRefGoogle Scholar
  76. 76.
    McKeon, F. 1991. When worlds collide: immunosuppressants meet protein phosphatases. Cell. 66:823–826.PubMedCrossRefGoogle Scholar
  77. 77.
    Meyaard, L., S. Otto, R. Jonker, M. Mijnster, R. Keet and F. Miedema. 1992. Programmed death of T cells in HIV-1 infection. Science. 257:217–219.PubMedCrossRefGoogle Scholar
  78. 78.
    Myers, G., K. Maclnnes and B. Korber. 1992. The emergences of simian/human immunodeficiency viruses. AIDS Res. Human Retrovir. 8:373.CrossRefGoogle Scholar
  79. 79.
    Nabel, G. and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature. 326:711–713.PubMedCrossRefGoogle Scholar
  80. 80.
    O’Keefe, S. J., J. Tamura, R. L. Kincaid, M. J. Tocci and E. A. O’Neill. 1992. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature. 357:692–694.PubMedCrossRefGoogle Scholar
  81. 81.
    Pal, R., M. S. Reitz Jr., E. Tschachler, R. C. Gallo, M. G. Sarnagadharan and F. D. M. Veronese. 1990. Myristylation of gag proteins of HIV-1 plays an important role in virus assembly. AIDS Res. Hum. Retroviruses. 6:721–730.CrossRefGoogle Scholar
  82. 82.
    Pantaleo, G., C. Graziosi and A. Fauci. 1993. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328:327–335.PubMedCrossRefGoogle Scholar
  83. 83.
    Pantaleo, G., M. Vaccarezza, O. J. Cohen, R. H. Hohman and A. S. Fauci. Cyclosporin A suppresses HIV-1 infection in primary T lymphocytes acutely infected in vitro. IXth International Conference on AIDS. 246, 1993.Google Scholar
  84. 84.
    Park, J. and C. D. Morrow. 1992. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles. J. Virol. 66:6304–6313.PubMedGoogle Scholar
  85. 85.
    Paxton, W., R. I. Connor and N. R. Landau. 1993. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for p6 region of gag and mutational analysis. J. Virol. 67:7229–7237.PubMedGoogle Scholar
  86. 86.
    Peng, C., B. Ho, T. Chang and N. Chang. 1989. Role of human immunodeficiency virus type 1 specific protease in core maturation and viral infectivity. J. Virol. 63:2550–2556.PubMedGoogle Scholar
  87. 87.
    Price, E. R., L. D. Zydowsky, M. Jin, C. H. Baker, F. D. McKeon and C. T. Walsh. 1991. Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. Proc. Natl. Acad. Sci. USA. 88:1903–1907.PubMedCrossRefGoogle Scholar
  88. 88.
    Ramsay, G. and M. J. Hayman 1980. Analysis of cells transformed by defective leukemia virus OK10: production of noninfectious particles and synthesis of Pr76gag and an additional 200,000-dalton protein. Virology. 106:71–81.PubMedCrossRefGoogle Scholar
  89. 89.
    Rebai, N., G. Pantaleo, J. F. Demarest, C. Ciurli, H. Soudeyns, J. W. Adelsberger, M. Vaccarezza, R. E. Walker, R. P. Sekaly and A. S. Fauci. 1994. Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbation of specific V beta segments in CD4+ T cells of the virus-positive twins. Proc. Natl. Acad. Sci. USA. 91:1529–1533.PubMedCrossRefGoogle Scholar
  90. 90.
    Rein, A., M. McClure, N. Rice, R. Luftig and A. Schultz. 1986. Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc. Natl. Acad. Sci., USA. 83:7246–7250.PubMedCrossRefGoogle Scholar
  91. 91.
    Rhee, S. S. and E. Hunter. 1987. Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J. Virol. 61:1045–1053.PubMedGoogle Scholar
  92. 92.
    Rosenwirth, B., A. Billich, R. Datema, P. Donatsch, F. Hammerschmid, R. Harrison, P. Hiestand, H. Jaksche, P. Mayer, P. Peichl, V. Quesniaux, F. Schatz, H.-J. Schuurman, R. Traber, R. Wenger, B. Wolff, G. Zenke and M. Zurini. 1994. Inhibition of HIV-1 replication by SDC NIM 811, a non-immunosuppressive cyclosporin A analogue. Antimicro. Agents Chemother. 38:1763–1772.CrossRefGoogle Scholar
  93. 93.
    Schreiber, S. L. and G. R. Crabtree. 1992. The mechanism of action of cyclosporin A and FK506. Immunology Today. 13:136–142.PubMedCrossRefGoogle Scholar
  94. 94.
    Schultz, A. M. and A. Rein. 1989. Unmyristoylated Moloney murine leukemia virus Pr65gag is excluded from virus assembly and maturation events. J. Virol. 63:2370–2373.PubMedGoogle Scholar
  95. 95.
    Schwartz, O., M. Alizon, J. M. Heard and O. Danos. 1994. Impairment of t cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. Virology. 198:360–365.PubMedCrossRefGoogle Scholar
  96. 96.
    Schwarz, A., G. Offermann, F. Keller, I. Bennhold, J. L’Age-Stehr, P. H. Krause and M. J. Mihatsch. 1993. The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation - Data on four cases and review of the literature. Transplantation. 55:95–103.PubMedCrossRefGoogle Scholar
  97. 97.
    Shearer, G. and M. Clerici. 1991. Early T-helper cell defects in HIV infection. AIDS. 5:245–253.PubMedCrossRefGoogle Scholar
  98. 98.
    Shi, Y., B. M. Sahai and D. R. Green. 1989. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature. 339:625–626.PubMedCrossRefGoogle Scholar
  99. 99.
    Shields, A., O. N. Witte, E. Rothenberg and D. Baltimore. 1978. High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections. Cell. 14:601–609.PubMedCrossRefGoogle Scholar
  100. 100.
    Shioda, T. and H. Shibuta. 1992. Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology. 175:139–148.CrossRefGoogle Scholar
  101. 101.
    Sigal, N. H., F. Dumont, P. Durette, J. J. Siekierka, L. Peterson, D. H. Rich, B. E. Dunlap, M. J. Staruch, M. R. Melino, S. L. Koprak, D. Williams, B. Witzel and J. M. Pisano. 1991. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? J. Exp. Med. 173:619–628.PubMedCrossRefGoogle Scholar
  102. 102.
    Skowronski, J., D. Parks and R. Mariani. 1993. Altered T cell activaton and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12:703–713.PubMedGoogle Scholar
  103. 103.
    Smith, A. J., N. Srinivasakumar, M.-L. Hanunarskjold and D. Rekosh. 1993. Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles. J. Virol. 67:2266–2275.PubMedGoogle Scholar
  104. 104.
    Smith, D. B. and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Excherichia coli as fusions with glutathione S-transferase. Gene. 67:31–40.PubMedCrossRefGoogle Scholar
  105. 105.
    Sodroski, J., W. C. Goh, C. Rosen, K. Campbell and W. A. Haseltine. 1986. Role of the HTLV III/LAV envelope in syncytium formation and cytopathicity. Nature. 322:470–474.PubMedCrossRefGoogle Scholar
  106. 106.
    Stamnes, M. A., S. L. Rutherford and C. S. Zuker. 1992. Cyclophilins: a new family of proteins involved in intracellular folding. Trends in Cell. Biol. 2:272–276.Google Scholar
  107. 107.
    Steinmann, B, P. Bruckner and A. Superti-Furga. 1991. cyclosporin A slows collagen triple-helix formation in vivo: Indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase. J. Biol. Chem. 266:1299–1303.PubMedGoogle Scholar
  108. 108.
    Strambio-de-Castillia, C. and E. Hunter. 1992. Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis. J. Virol. 66:7021–7032.PubMedGoogle Scholar
  109. 109.
    Strebel, K., T. Klimkait, F. Maldarelli and M. A. Martin. 1989. Molecular and biochemical analysis of human immunodeficiency virus type 1 vpu protein. J. Virol. 63:3784–3791.PubMedGoogle Scholar
  110. 110.
    Sykes, K., M.-J. Gething and J. Sambrook. 1993. Proline isomerases function during heat shock. Proc. Natl. Acad. Sci. USA. 90:5853–5857.PubMedCrossRefGoogle Scholar
  111. 111.
    Terai, C., R. Kornbluth, C. Pauza, D. Richman and D. Carson. 1991. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J. Clin. Invest. 87:1710–1715.PubMedCrossRefGoogle Scholar
  112. 112.
    Thali, M., A. A. Bukovsky, E. Kondo, B. Rosenwirth, C. T. Walsh, J. Sodroski and H. G. Goettlinger. 1994. Specific association of cyclophilin A with human immunodeficiency virus type 1 virions. Submitted.Google Scholar
  113. 113.
    Tristem, M., C. Marshall, A. Karpas and F. Hill. 1992. Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J. 11:3405–3412.Google Scholar
  114. 114.
    Vojtek, A. B., S. M. Hollenberg and J. A. Cooper. 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell. 774:205–214.CrossRefGoogle Scholar
  115. 115.
    Wainberg, M., A. Dascal, N. Blain, L. Fitz-Gibbon, F. Boulerice, K. Numazaki and M. Tremblay. 1988. The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. Blood. 72:1904–1910.PubMedGoogle Scholar
  116. 116.
    Walsh, C. T., L. D. Zydowsky and F. D. McKeon. 1992. Cyclosporin A, the cyclophilin class of petidylprolyl isomerases, and blockade of T cell signal transduction. J. Biol. Chem. 267:13115–13118.PubMedGoogle Scholar
  117. 117.
    Wang, C.-T. and E. Barklis. 1993. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J. Virol. 67:4264–4273.PubMedGoogle Scholar
  118. 118.
    Wang, T., P. K. Donahoe and A. S. Zervos. 1994. Specific interaction of type I receptors of the TGF- 3 family with the immunophilin FKBP-12. Science. 265:674–676.PubMedCrossRefGoogle Scholar
  119. 119.
    Weinhold, K., H. Lyerly, S. Stanley, A. Austin, T. Matthews and D. Bolognesi. 1989. HIV-1 pg120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J. Immunol. 142:3091–3097.PubMedGoogle Scholar
  120. 120.
    Weiss, R. A. 1989. Defective viruses to blame? Nature. 338:458.PubMedCrossRefGoogle Scholar
  121. 121.
    Yu, X.-F., M. Matsuda, M. Essex and T.-H. Lee. 1990. Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein. J. Virol. 64:5688–5693.PubMedGoogle Scholar
  122. 122.
    Zervos, A., J. Gyuris and R. Brent. 1993. Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell. 72:223–232.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Ettaly Kara Franke
    • 1
  • Jeremy Luban
    • 1
  1. 1.Department of MedicineColumbia University College of Physicians and SurgeonsNew YorkUSA

Personalised recommendations